Chiusura precedente | 2,9600 |
Aperto | 2,9900 |
Denaro | 0,0000 x 0 |
Lettera | 0,0000 x 0 |
Min-Max giorno | 2,7501 - 3,0300 |
Intervallo di 52 settimane | 1,8900 - 8,0000 |
Volume | |
Media Volume | 41.377 |
Capitalizzazione | 3,875M |
Beta (5 anni mensile) | -1,10 |
Rapporto PE (ttm) | 0,56 |
EPS (ttm) | 5,0000 |
Prossima data utili | 30 apr 2024 - 04 mag 2024 |
Rendimento e dividendo (futuro) | N/D (N/D) |
Data ex dividendo | N/D |
Stima target 1A | 77,50 |
XI’AN, China, Oct. 06, 2023 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), one of the leading bio-ingredient solutions providers in the natural, health and personal care industries, today announced the signing of a Memorandum of Understanding with Guangdong Jiangwang International Holdings Limited (“Jiangwang”) . This MOU allows the parties to negotiate the terms and conditions of a definitive agreement for BON to distribute Jiangwang’s Chinese White Spirits
XI’AN, China, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) (“BON” or the “Company”), one of the leading bio-ingredient solutions providers in the natural, health and personal care industries, today announced its half-year financial results for the six months ended March 31, 2023. 1H-2023 Financial Highlights Revenue - Total revenues were $14.1 million, representing a 3.4% increase from US$13.7 million for the same period in 2022.Income from operation – for the six mo
XI’AN, China, July 07, 2023 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), one of the leading bio-ingredient solutions providers in the natural, health and personal care industries, today announced that the Company received a letter (the “Notification Letter”) from the Nasdaq Stock Market LLC (“Nasdaq”) on June 30, 2023, due to the resignations of Messrs. James Edward Burns, Lawrence W. Leighton, and Jeffrey J. Guzy from the Company’s Board of Directors and